Here are four things to know:
1. The device is intended for patients with degenerative disc disease at one or two levels from L2- to S1.
2. The OmegaLIF has an expansion mechanism and a cannulated bullet nose design for insertion.
3. Amendia plans to launch several other products in 2016. The company offers cervical, lumbar and interventional spinal devices.
4. “We’re confident that it will positively impact our mission of improving surgical outcomes and bettering the lives of patients with spinal disorders, while simultaneously increasing our product portfolio, allowing us to offer a complete, dynamic medical device line to spine surgeons,” said Jeff Smith, CEO, Amendia.
More articles on devices:
Should medical device companies advertise direct to consumers?
Globus Medical shares fall 1%: 5 points
Analysts expect NuVasive to report $0.3 earnings per share: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
